Haematology | |
WBC | 9900/μl |
Neu | 74% |
Eo | 3% |
Ba | 1% |
Mo | 6% |
Ly | 16% |
RBC | 328×104/μl |
Hb | 9.8 g/dl |
Hct | 29.4% |
MCV | 89.6 fl |
MCH | 29.9 pg |
MCHC | 33.3% |
Plt | 35.0×104/μl |
Biochemistry | |
TP | 7.1 g/dl |
Alb | 3.4 g/dl |
BUN | 25 mg/dl |
Cr | 1.07 mg/dl |
Na | 134 mEq/l |
K | 3.4 mEq/l |
Cl | 101 mEq/l |
Ca | 8.9 mg/dl |
LDH | 204 U/l |
AST | 15 U/l |
ALT | 11 U/l |
ALP | 264 U/l |
T-Bil | 0.3 mg/dl |
CK | 73 IU/l |
Serology | |
CRP | 0.97 mg/dl |
IgG | 1724 mg/dl |
IgA | 641 mg/dl |
IgM | 99 mg/dl |
ACE | 13.2 IU/l |
Lysozyme | 13.2 μg/ml |
KL-6 | 710 U/ml |
RF | 81 IU/ml |
MPO-ANCA | <10 EU |
PR3-ANCA | <10 EU |
ESR | 69 mm/h |
Tumour markers | |
CEA | 2.9 ng/ml |
CA19-9 | 15.6 IU/ml |
sIL-2R | 1930 U/ml |
PPD skin test (−) | |
Viral infection | |
HIV-Ab (−) | |
HTLV-1-Ab (+) | ×262144 (serum)×32 (CSF) |
HTLV-1 provirus (CSF) | 4.5×104 copy/ml (free) 1.4×103 copy/ml (intracellular) |
BALF | |
Total cell count 35.7×104/ml | |
Mo | 94.5% |
Neu | 1.0% |
Ly | 4.5% |
Eo | 0.0% |
CD4:CD8 ratio 1.4 |
ACE, angiotensin-converting enzyme; Alb, albumin; ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate aminotransferase; Ba, basophils; BALF, bronchoalveolar lavage fluid; BUN, blood urea nitrogen; CEA, carcinoembryonic antigen; CK, creatine kinase; Cr, creatinine; CRP, C reactive protein; CSF, cerebrospinal fluid; Eo, eosinophils; ESR, erythrocyte sedimentation rate; Hb, haemoglobin; Hct, haematocrit; HTLV-1-Ab, human T-lymphotropic virus type 1 antibody; LDH, lactate dehydrogenase; Ly, lymphocytes; MCH, mean corpuscular haemoglobin; MCHC, mean corpuscular haemoglobin concentration; MCV, mean corpuscular volume; Mo, monocytes; MPO-ANCA, myeloperoxidase antineutrophil cytoplasmic antibodies; Neu, neutrophils; Plt, platelet count; PPD, purified protein derivative; RBC, red blood cell; RF, rheumatoid factor; T-Bil, total bilirubin; TP, total protein; WBC, white blood cell.